63 results on '"Schwebke J"'
Search Results
2. P417 Risk of Chlamydia and Gonorrhea among young African American women with Persistent and Episodic Bacterial Vaginosis
3. Results of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of astodrimer gel for prevention of recurrent bacterial vaginosis
4. Impact of vaginal washing on the vaginal microbiota
5. Susceptibility of trichomonas vaginalis clinical isolates to secnidazole and metronidazole
6. Impact of vaginal bacteria on the presence and clinical presentation of vaginal yeast colonization
7. Clinical performance of the Solana® Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women
8. 16: A phase 3 randomized, double-blind, placebo-controlled study to confirm the efficacy and safety of a single, oral dose of SYM-1219, a granule formulation containing 2 grams of secnidazole, for the treatment of bacterial vaginosis
9. 3: Detection of macrolide resistance-mediating mutations among women with mycoplasma genitalium infection in the preventing vaginal infections trial
10. 34: Incidence and predictors of re-infection with trichomoniasis based on nucleic acid amplification testing results in HIV-infected patients
11. 4: Associations between hormonal contraceptive methods and the vaginal microbiota
12. 9: Lack of association of gardnerella vaginalis clades with development of bacterial vaginosis
13. 8: Missed opportunities for trichomonas vaginalis diagnosis and treatment at an urban HIV clinic
14. O10.5 Rapid diagnosis oftrichomonas vaginalisby testing vaginal swabs in an isothermal helicase-dependent amplivue®assay
15. 006.5 Periodic presumptive treatment for vaginal infections may reduce chlamydia and gonorrhoea incidence: a secondary analysis from the preventing vaginal infections trial
16. P06.11 The impact of periodic presumptive treatment for vaginal infections on the vaginal microbiome among women participating in the preventing vaginal infections trial
17. Women Who Have Sex With Women: A Unique Population for Studying the Pathogenesis of Bacterial Vaginosis
18. Added Benefit of Nucleic Acid Amplification Testing for the Diagnosis of Trichomonas vaginalis Among Men and Women Attending a Sexually Transmitted Diseases Clinic
19. ESwab as an Optional Collection Device for Use with the Affirm VPIII Microbial Test System
20. P2.074 Comparison of Specimen Type For the Diagnosis ofTrichomonasVaginalis(TV) Using the ViperTMSystem is Extracted Mode
21. P2.075 Evaluation of Female Urine and Vaginal Swabs Using the BD ProbeTec™Trichomonas VaginalisQxAmplified DNA Assay on the BD Viper™ System in Extracted Mode and a Cleared NAAT TV Assay as Compared to PIS
22. P2.109 Sexual Transmission of Bacterial Vaginosis Without Exposure to Seminal Fluid
23. P1.036 Lack of Evidence For Sexual Transmission of GenitalCandida AlbicansIsolates Among Women Who Have Sex with Women in Sexual Partnerships
24. P5.093 Evaluation of a New Amplified DNA Assay on the Becton Dickinson Viper System in Extracted Mode For the Detection ofTrichomonas Vaginalisfrom Vaginal Specimens
25. P2.145 Adherence to Repeated Home Screening For Bacterial Vaginosis and STIs Among Young Women Participating in the BRAVO Randomized Clinical Trial
26. Gardnerella vaginalis: Still a Prime Suspect in the Pathogenesis of Bacterial Vaginosis
27. Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis Infections in Men With Nongonococcal Urethritis: Predictors and Persistence After Therapy
28. P3-S7.05 Phenotypic characterisation of clinical trichomonas vaginalis isolates among AAWSW in sexual partnerships
29. P3-S7.08 Clinical evaluation of the APTIMA(R) Trichomonas vaginalis assay on the TIGRIS(R) DTS(R) system in asymptomatic and symptomatic female subjects
30. O5-S4.03 HIV testing among patients infected with Neisseria gonorrhoeae-STD surveillance network, USA, 2009-2010
31. P3-S1.32 A validation study of the Gen-Probe APTIMA Combo2 (AC2) assay for detecting Chlamydia trachomatis and Neisseria gonorrhoeae in dry swabs
32. P1-S1.51 Prevalence of anogenital Warts among STD clinic patients-STD surveillance network, USA, January 2010-September 2010
33. Re-Evaluating the Treatment of Nongonococcal Urethritis: Emphasizing Emerging Pathogens-A Randomized Clinical Trial
34. Viability of Trichomonas vaginalis in Copan Universal Transport Medium and eSwab Transport Medium
35. A Longitudinal Study of Vaginal Douching and Bacterial Vaginosis--A Marginal Structural Modeling Analysis
36. The polymicrobial hypothesis of bacterial vaginosis causation: a reassessment
37. A Randomized Trial of the Duration of Therapy with Metronidazole plus or minus Azithromycin for Treatment of Symptomatic Bacterial Vaginosis
38. The Relationship Between Bacterial Vaginosis(BV) and Dietary Intake
39. An international study of the interobserver variation between interpretations of vaginal smear criteria of bacterial vaginosis
40. Update of trichomoniasis
41. Antimicrobial resistance among Neisseria gonorrhoeae isolates from Ulaanbaatar, Mongolia
42. Influence of the Normal Menstrual Cycle on Vaginal Microflora
43. Screening for Latent Tuberculosis in Sexually Transmitted Disease Clinics
44. Viability of Trichomonas vaginalis in Transport Medium
45. Comparison of Direct Inoculation and Copan Transport Systems for Isolation of Neisseria gonorrhoeae from Endocervical Specimens
46. Sexually transmitted diseases in Ulaanbaatar, Mongolia
47. Bacterial vaginosis--more questions than answers.
48. Effect of concurrent lower genital tract infections on cervical cancer screening.
49. Validity of self-obtained vaginal specimens for diagnosis of trichomoniasis
50. Validity of the Vaginal Gram Stain for the Diagnosis of Bacterial Vaginosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.